Data / Drug companies / Ampicillin sodium and sulbactam sodium
Ampicillin sodium and sulbactam sodium: 7 companies and 24 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Ampicillin sodium and sulbactam sodium is listed in the FDA National Drug Code Directory by 7 companies, with 24 products in commercial distribution. 21 of the products (87.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, powder, for solution, and the newest product started marketing on September 8, 2025.
The request: Get every company that lists ampicillin sodium and sulbactam sodium in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 7
- Products
- 24
- Generic (ANDA) products
- 21 (87.5%)
- Application numbers
- 9
- Routes
- Intravenous, Intramuscular
- Brand names
- Ampicillin and Sulbactam, Unasyn
- openFDA record search
- api.fda.gov
Companies that list ampicillin sodium and sulbactam sodium
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Eugia US LLC | 8 | injection, powder, for solution | Generic drugs (ANDA) | September 13, 2012 |
| Meitheal Pharmaceuticals Inc. | 6 | injection, powder, for solution | Generic drugs (ANDA) | November 27, 2006 |
| NorthStar RxLLC | 3 | injection, powder, for solution | Generic drugs (ANDA) | March 1, 2024 |
| Roerig | 3 | injection, powder, for solution | New drug applications (NDA) | November 22, 1991 |
| Onesource Specialty Pharma Limited | 2 | injection, powder, for solution | Generic drugs (ANDA) | April 14, 2023 |
| Civica, Inc. | 1 | injection, powder, for solution | Generic drugs (ANDA) | September 8, 2025 |
| Medical Purchasing Solutions, LLC | 1 | injection, powder, for solution | Generic drugs (ANDA) | February 10, 2012 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, powder, for solution | 24 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 21 | 87.5% |
| New drug applications (NDA) | 3 | 12.5% |
Pharmacologic classes
| Class | Products |
|---|---|
| Penicillin-class Antibacterial | 24 |
| beta Lactamase Inhibitor | 24 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.